Announcements Trials
Browse Landscape

Phase

Phase NA 30Phase 3 3Phase 2 3

Status

Completed 11Recruiting 3Active not recruiting 3Unknown 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Lymphoma 1Hematologic Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Early Intervention, Educational × Clear all
NCT07186192 2026-01-28

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

City of Hope Medical Center

Phase 3 Recruiting
190 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT06763328 2026-01-22

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

City of Hope Medical Center

Phase 3 Recruiting
200 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting
668 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡